MAAB
MAAB Group is a family-owned investment and trading company specializing in the international commercialization of pioneering healthcare products. Founded in 2011 by pharmaceutical industry veterans, the company moved its global headquarters from Hong Kong to New Zealand in 2020 and now operates in mainland China, Denmark, and the UK. They leverage their expertise and global supply network to deliver innovative products, ranging from diagnostic medical devices to consumer healthcare items, primarily from Europe and the UK to China and Australasia. Their focus includes evidence-based probiotic products and AI-enabled diagnostic solutions for neurodegenerative conditions, aiming to translate pioneering scientific research into practical applications. MAAB Group seeks to partner with like-minded entrepreneurs and healthcare professionals to globalize their innovative products.
MAAB
MAAB Group is a family-owned investment and trading company specializing in the international commercialization of pioneering healthcare products. Founded in 2011 by pharmaceutical industry veterans, the company moved its global headquarters from Hong Kong to New Zealand in 2020 and now operates in mainland China, Denmark, and the UK. They leverage their expertise and global supply network to deliver innovative products, ranging from diagnostic medical devices to consumer healthcare items, primarily from Europe and the UK to China and Australasia. Their focus includes evidence-based probiotic products and AI-enabled diagnostic solutions for neurodegenerative conditions, aiming to translate pioneering scientific research into practical applications. MAAB Group seeks to partner with like-minded entrepreneurs and healthcare professionals to globalize their innovative products.